P82251 (BAT1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 127.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: B(0,+)-type amino acid transporter 1 Short name=B(0,+)AT Alternative name(s): Glycoprotein-associated amino acid transporter b0,+AT1 Solute carrier family 7 member 9 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 487 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system b(0,+)-like activity). Thought to be responsible for the high-affinity reabsorption of cystine in the kidney tubule. Ref.1 |
| Subunit structure | Disulfide-linked heterodimer with the amino acid transport protein SLC3A1. |
| Subcellular location | Membrane; Multi-pass membrane protein Probable. |
| Tissue specificity | Kidney, small intestine, liver and placenta. Ref.1 |
| Involvement in disease | Cystinuria (CSNU) [MIM:220100]: An autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure. |
| Sequence similarities | Belongs to the amino acid-polyamine-organocation (APC) superfamily. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 487 | 487 | B(0,+)-type amino acid transporter 1 | PRO_0000054258 | |||||
Regions | |||||||||
| Topological domain | 1 – 29 | 29 | Cytoplasmic Potential | ||||||
| Transmembrane | 30 – 50 | 21 | Helical; Potential | ||||||
| Topological domain | 51 – 60 | 10 | Extracellular Potential | ||||||
| Transmembrane | 61 – 81 | 21 | Helical; Potential | ||||||
| Topological domain | 82 – 99 | 18 | Cytoplasmic Potential | ||||||
| Transmembrane | 100 – 120 | 21 | Helical; Potential | ||||||
| Topological domain | 121 – 148 | 28 | Extracellular Potential | ||||||
| Transmembrane | 149 – 169 | 21 | Helical; Potential | ||||||
| Topological domain | 170 – 178 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 179 – 199 | 21 | Helical; Potential | ||||||
| Topological domain | 200 – 210 | 11 | Extracellular Potential | ||||||
| Transmembrane | 211 – 231 | 21 | Helical; Potential | ||||||
| Topological domain | 232 – 251 | 20 | Cytoplasmic Potential | ||||||
| Transmembrane | 252 – 272 | 21 | Helical; Potential | ||||||
| Topological domain | 273 – 296 | 24 | Extracellular Potential | ||||||
| Transmembrane | 297 – 317 | 21 | Helical; Potential | ||||||
| Topological domain | 318 – 348 | 31 | Cytoplasmic Potential | ||||||
| Transmembrane | 349 – 369 | 21 | Helical; Potential | ||||||
| Topological domain | 370 – 374 | 5 | Extracellular Potential | ||||||
| Transmembrane | 375 – 395 | 21 | Helical; Potential | ||||||
| Topological domain | 396 – 409 | 14 | Cytoplasmic Potential | ||||||
| Transmembrane | 410 – 430 | 21 | Helical; Potential | ||||||
| Topological domain | 431 – 434 | 4 | Extracellular Potential | ||||||
| Transmembrane | 435 – 455 | 21 | Helical; Potential | ||||||
| Topological domain | 456 – 487 | 32 | Cytoplasmic Potential | ||||||
Natural variations | |||||||||
| Natural variant | 10 | 1 | Missing in CSNU. Ref.7 | VAR_018997 | |||||
| Natural variant | 44 | 1 | I → T in CSNU; type I. Ref.4 | VAR_014363 | |||||
| Natural variant | 52 | 1 | P → L in CSNU. Ref.7 | VAR_018998 | |||||
| Natural variant | 63 | 1 | G → R in CSNU. Ref.7 | VAR_018999 | |||||
| Natural variant | 69 | 1 | W → L in CSNU. Ref.7 | VAR_019000 | |||||
| Natural variant | 70 | 1 | A → V in CSNU; mild loss of amino acid transport activity. Ref.7 | VAR_019001 | |||||
| Natural variant | 105 | 1 | G → R in CSNU; type III; frequent mutation; severe loss of amino acid transport activity. Ref.1 Ref.7 Ref.8 | VAR_010256 | |||||
| Natural variant | 123 | 1 | T → M in CSNU. Ref.7 | VAR_019002 | |||||
| Natural variant | 126 | 1 | A → T in CSNU. Ref.7 | VAR_019003 | |||||
| Natural variant | 142 | 1 | V → A. Corresponds to variant rs12150889 [ dbSNP | Ensembl ]. | VAR_048153 | |||||
| Natural variant | 158 | 1 | A → AA in CSNU. Ref.7 | VAR_019004 | |||||
| Natural variant | 170 | 1 | V → M in CSNU; type III; frequent mutation; complete loss of amino acid transport activity. Ref.1 Ref.7 | VAR_010257 | |||||
| Natural variant | 182 | 1 | A → T in CSNU; type III; frequent mutation; mild loss of amino acid transport activity. Ref.1 Ref.7 Ref.9 | VAR_010258 | |||||
| Natural variant | 187 | 1 | I → F in CSNU. Ref.7 | VAR_019005 | |||||
| Natural variant | 193 | 1 | I → II in CSNU. Ref.7 | VAR_019006 | |||||
| Natural variant | 195 | 1 | G → R in CSNU; type III. Ref.1 Ref.7 | VAR_010259 | |||||
| Natural variant | 223 | 1 | L → M. Ref.4 Corresponds to variant rs1007160 [ dbSNP | Ensembl ]. | VAR_019007 | |||||
| Natural variant | 224 | 1 | A → V in CSNU; non-classic type I. Ref.8 | VAR_022603 | |||||
| Natural variant | 230 | 1 | W → R in CSNU. Ref.7 | VAR_019008 | |||||
| Natural variant | 241 | 1 | I → T in CSNU. Ref.7 | VAR_019009 | |||||
| Natural variant | 244 | 1 | Missing in CSNU. Ref.7 | VAR_019010 | |||||
| Natural variant | 259 | 1 | G → R in CSNU; type III. Ref.1 Ref.7 | VAR_010260 | |||||
| Natural variant | 261 | 1 | P → L in CSNU; types I and III. Ref.4 Ref.9 | VAR_014364 | |||||
| Natural variant | 330 | 1 | V → M in CSNU; type III. Ref.9 | VAR_015885 | |||||
| Natural variant | 331 | 1 | A → V in CSNU; non-classic type I. Ref.8 | VAR_022604 | |||||
| Natural variant | 333 | 1 | R → W in CSNU; frequent mutation; severe loss of amino acid transport activity. Ref.7 | VAR_019011 | |||||
| Natural variant | 354 | 1 | A → T in CSNU; type III; severe loss of amino acid transport activity. Ref.4 Ref.7 | VAR_014365 | |||||
| Natural variant | 379 | 1 | S → R in CSNU. Ref.7 | VAR_019012 | |||||
| Natural variant | 382 | 1 | A → T in CSNU. Ref.7 | VAR_019013 | |||||
Experimental info | |||||||||
| Sequence conflict | 52 | 1 | P → S in CAB54003. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (b0,+AT) of rBAT." Feliubadalo L., Font M., Purroy J., Rousaud F., Estivill X., Nunes V., Golomb E., Centola M., Aksentijevich I., Kreiss Y., Goldman B., Pras M., Kastner D.L., Pras E., Gasparini P., Bisceglia L., Beccia E., Gallucci M. Palacin M.Nat. Genet. 23:52-57(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS CSNU ARG-105; MET-170; THR-182; ARG-195 AND ARG-259, CHARACTERIZATION OF VARIANT CSNU MET-170, FUNCTION, TISSUE SPECIFICITY. Tissue: Kidney. |
| [2] | "Luminal heterodimeric amino acid transporter defective in cystinuria." Pfeiffer R., Loffing J., Rossier G., Bauch C., Meier C., Eggermann T., Loffing-Cueni D., Kuehn L.C., Verrey F. Mol. Biol. Cell 10:4135-4147(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Kidney. |
| [3] | "Human cystinuria-related transporter: localization and functional characterization." Mizoguchi K., Cha S.H., Chairoungdua A., Kim J.Y., Shigeta Y., Matsuo H., Fukushima J., Awa Y., Akakura K., Goya T., Ito H., Endou H., Kanai Y. Kidney Int. 59:1821-1833(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Kidney. |
| [4] | "SLC7A9 mutations in all three cystinuria subtypes." Leclerc D., Boutros M., Suh D., Wu Q., Palacin M., Ellis J.R., Goodyer P., Rozen R. Kidney Int. 62:1550-1559(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CSNU THR-44; LEU-261 AND THR-354, VARIANT MET-223. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [7] | "Functional analysis of mutations in SLC7A9, and genotype-phenotype correlation in non-type I cystinuria." Font M., Feliubadalo L., Estivill X., Nunes V., Golomb E., Kreiss Y., Pras E., Bisceglia L., d'Adamo A.P., Zelante L., Gasparini P., Bassi M.T., George A.L. Jr., Manzoni M., Riboni M., Ballabio A., Borsani G., Reig N. Palacin M.Hum. Mol. Genet. 10:305-316(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CSNU ARG-10 DEL; LEU-52; ARG-63; LEU-69; VAL-70; ARG-105; MET-123; THR-126; ALA-158 INS; MET-170; THR-182; PHE-187; ILE-193 INS; ARG-195; ARG-230; THR-241; GLU-244 DEL; ARG-259; TRP-333; THR-354; ARG-379 AND THR-382, CHARACTERIZATION OF VARIANTS CSNU VAL-70; ARG-105; MET-170; THR-182; TRP-333 AND THR-354. |
| [8] | "Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes." Botzenhart E., Vester U., Schmidt C., Hesse A., Halber M., Wagner C., Lang F., Hoyer P., Zerres K., Eggermann T. Kidney Int. 62:1136-1142(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CSNU ARG-105; VAL-224 AND VAL-331. |
| [9] | "Mutation analysis of SLC7A9 in cystinuria patients in Sweden." Harnevik L., Fjellstedt E., Molbaek A., Denneberg T., Soderkvist P. Genet. Test. 7:13-20(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CSNU THR-182; LEU-261 AND MET-330. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF141289 mRNA. Translation: AAD55898.1. AJ249199 mRNA. Translation: CAB54003.1. AB033548 mRNA. Translation: BAB16840.1. AF421181 AF421180 Genomic DNA. Translation: AAN40878.1.AK313708 mRNA. Translation: BAG36453.1. BC017962 mRNA. Translation: AAH17962.1. |
| IPI | IPI00011357. |
| RefSeq | NP_001119807.1. NM_001126335.1. NP_001229965.1. NM_001243036.1. NP_055085.1. NM_014270.4. |
| UniGene | Hs.408567. |
3D structure databases | |
| ProteinModelPortal | P82251. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P82251. 1 interaction. |
| STRING | 9606.ENSP00000023064. |
PTM databases | |
| PhosphoSite | P82251. |
Polymorphism databases | |
| DMDM | 12585187. |
Proteomic databases | |
| PRIDE | P82251. |
Protocols and materials databases | |
| DNASU | 11136. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000023064; ENSP00000023064; ENSG00000021488. ENST00000587772; ENSP00000468439; ENSG00000021488. ENST00000590341; ENSP00000464822; ENSG00000021488. |
| GeneID | 11136. |
| KEGG | hsa:11136. |
| UCSC | uc002ntu.4. human. |
Organism-specific databases | |
| CTD | 11136. |
| GeneCards | GC19M033321. |
| HGNC | HGNC:11067. SLC7A9. |
| HPA | HPA042591. |
| MIM | 220100. phenotype. 604144. gene. |
| neXtProt | NX_P82251. |
| Orphanet | 93613. Cystinuria type B. |
| PharmGKB | PA35927. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0531. |
| HOGENOM | HOG000098892. |
| HOVERGEN | HBG000476. |
| InParanoid | P82251. |
| KO | K13868. |
| OMA | ERNGSTQ. |
| OrthoDB | EOG4P8FJ2. |
| PhylomeDB | P82251. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. REACT_19419. Amino acid and oligopeptide SLC transporters. REACT_604. Hemostasis. |
Gene expression databases | |
| Bgee | P82251. |
| CleanEx | HS_BAT1. HS_SLC7A9. |
| Genevestigator | P82251. |
| GermOnline | ENSG00000021488. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR002293. AA/rel_permease1. [Graphical view] |
| PANTHER | PTHR11785. PTHR11785. 1 hit. |
| PIRSF | PIRSF006060. AA_transporter. 1 hit. |
| ProtoNet | Search... |
Other | |
| DrugBank | DB00138. L-Cystine. |
| GenomeRNAi | 11136. |
| NextBio | 42332. |
| SOURCE | Search... |
Entry information
| Entry name | BAT1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P82251 Secondary accession number(s): B2R9A6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
